Basic Information
| LncRNA/CircRNA Name | DB327252 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | lung cancer |
| ICD-0-3 | C34 |
| Methods | qPCR, RNAi etc. |
| Sample | cell lines (A549, 16HBE-T) |
| Expression Pattern | up-regulated |
| Function Description | The results indicated that the expression of DB327252 was up-regulated in lung cancer tissues compared to the cancer-adjacent normal tissues; and the up-regulated expression is likely to relate to those with bigger tumor size, adenocarcinoma and advanced TNM stage. In addition, the knockdown of DB327252 inhibited the growth and proliferation of tumor cell in vitro and in vivo. |
| Pubmed ID | 27867555 |
| Year | 2016 |
| Title | Functional role of lncRNA DB327252 in lung cancer. |
External Links
| Links for DB327252 | GenBank HGNC NONCODE |
| Links for lung cancer | OMIM COSMIC |